Wu et al. suggested that EZH2 promoted the expression of LPA1 by mediating microRNA-139 promoter methylation to accelerate the development of ovarian cancer [35], which is consistent with the results of our study. The gene discussed is EZH2; the disease is ovarian carcinoma.